Debt-free Balance SheetZero reported debt provides durable financial flexibility: it lowers bankruptcy risk, supports capital investments or M&A without raising leverage, and allows the company to absorb revenue shocks or fund working capital internally over the next several quarters.

Accelerating Revenue GrowthA shift from mid-single-digit to roughly 12% revenue growth signals improving demand or share gains in distribution. Sustained higher top-line momentum supports scale economics, potential margin recovery, and steadier free cash generation over a multi-quarter horizon.

Rising Equity And Positive FCF HistoryGradually rising equity and a history of positive free cash flow create a durable capital base to fund ops, dividends, and modest investments without debt. This enhances resilience and strategic optionality despite recent cash conversion swings.

Bears Say

Very Thin Net MarginsA roughly 1% net margin gives the business little buffer against cost inflation, pricing pressure, or client mix shifts. Persistently thin margins constrain reinvestment, limit spare cash for growth or dividends, and make profitability highly sensitive to operational disruptions.

Weakening Cash ConversionA sharp decline in cash conversion ratio reduces earnings quality and available cash for capex or distributions. If driven by working capital or receivable deterioration, it can persist for multiple quarters and increase reliance on equity or reserves to fund growth.

Inconsistent Operating Profit (EBIT)Volatile or declining EBIT indicates sensitivity to cost or price swings and undermines predictable free cash generation. Inconsistent operating profit complicates planning, weakens return on invested capital, and raises execution risk for multi-quarter strategies.

9265 FAQ

What was YAMASHITA HEALTH CARE HOLDINGS, INC.’s price range in the past 12 months?

YAMASHITA HEALTH CARE HOLDINGS, INC. lowest stock price was ¥2445.00 and its highest was ¥3915.00 in the past 12 months.

What is YAMASHITA HEALTH CARE HOLDINGS, INC.’s market cap?

YAMASHITA HEALTH CARE HOLDINGS, INC.’s market cap is ¥9.50B.

When is YAMASHITA HEALTH CARE HOLDINGS, INC.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were YAMASHITA HEALTH CARE HOLDINGS, INC.’s earnings last quarter?

Currently, no data Available

Is YAMASHITA HEALTH CARE HOLDINGS, INC. overvalued?

According to Wall Street analysts YAMASHITA HEALTH CARE HOLDINGS, INC.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does YAMASHITA HEALTH CARE HOLDINGS, INC. pay dividends?

YAMASHITA HEALTH CARE HOLDINGS, INC. pays a Annually dividend of ¥61 which represents an annual dividend yield of 1.87%. See more information on YAMASHITA HEALTH CARE HOLDINGS, INC. dividends here

What is YAMASHITA HEALTH CARE HOLDINGS, INC.’s EPS estimate?

YAMASHITA HEALTH CARE HOLDINGS, INC.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does YAMASHITA HEALTH CARE HOLDINGS, INC. have?

YAMASHITA HEALTH CARE HOLDINGS, INC. has 2,553,000 shares outstanding.

What happened to YAMASHITA HEALTH CARE HOLDINGS, INC.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of YAMASHITA HEALTH CARE HOLDINGS, INC.?

Currently, no hedge funds are holding shares in JP:9265

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

YAMASHITA HEALTH CARE HOLDINGS, INC.

Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, shadowless lights, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, calculus crushing devices, and stents. It also provides consulting services related to the management of medical and long-term care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reception, posting agency for customer satisfaction surveys, and network security systems sales. The company was founded in 1926 and is headquartered in Fukuoka City, Japan.